FR2131843A1 - - Google Patents

Info

Publication number
FR2131843A1
FR2131843A1 FR7111081A FR7111081A FR2131843A1 FR 2131843 A1 FR2131843 A1 FR 2131843A1 FR 7111081 A FR7111081 A FR 7111081A FR 7111081 A FR7111081 A FR 7111081A FR 2131843 A1 FR2131843 A1 FR 2131843A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7111081A
Other languages
French (fr)
Other versions
FR2131843B1 (cg-RX-API-DMAC10.html
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KARAMCHAND PREMCHAND PRIVATE
Original Assignee
KARAMCHAND PREMCHAND PRIVATE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US00078142A priority Critical patent/US3748325A/en
Priority to GB47210/70A priority patent/GB1298603A/en
Priority to CA108,437A priority patent/CA940927A/en
Priority to DE19712114607 priority patent/DE2114607A1/de
Application filed by KARAMCHAND PREMCHAND PRIVATE filed Critical KARAMCHAND PREMCHAND PRIVATE
Priority to FR7111081A priority patent/FR2131843B1/fr
Priority to CH491971A priority patent/CH556847A/de
Publication of FR2131843A1 publication Critical patent/FR2131843A1/fr
Application granted granted Critical
Publication of FR2131843B1 publication Critical patent/FR2131843B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/56—Amides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7111081A 1970-04-06 1971-03-30 Expired FR2131843B1 (cg-RX-API-DMAC10.html)

Priority Applications (6)

Application Number Priority Date Filing Date Title
US00078142A US3748325A (en) 1970-04-06 1970-10-05 Process for the preparation of quinazolinone derivatives
GB47210/70A GB1298603A (en) 1970-04-06 1970-10-05 Quinazolinone derivatives
CA108,437A CA940927A (en) 1970-04-06 1971-03-23 Process for the preparation of quinazolinone compounds
DE19712114607 DE2114607A1 (de) 1970-04-06 1971-03-26 Neue Chinazolinon-Derivate und Verfahren zu ihrer Herstellung
FR7111081A FR2131843B1 (cg-RX-API-DMAC10.html) 1970-04-06 1971-03-30
CH491971A CH556847A (de) 1970-04-06 1971-04-05 Verfahren zur herstellung neuer chinazolinon-derivate.

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN126066 1970-04-06
DE19712114607 DE2114607A1 (de) 1970-04-06 1971-03-26 Neue Chinazolinon-Derivate und Verfahren zu ihrer Herstellung
FR7111081A FR2131843B1 (cg-RX-API-DMAC10.html) 1970-04-06 1971-03-30
CH491971A CH556847A (de) 1970-04-06 1971-04-05 Verfahren zur herstellung neuer chinazolinon-derivate.

Publications (2)

Publication Number Publication Date
FR2131843A1 true FR2131843A1 (cg-RX-API-DMAC10.html) 1972-11-17
FR2131843B1 FR2131843B1 (cg-RX-API-DMAC10.html) 1974-05-24

Family

ID=27428832

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7111081A Expired FR2131843B1 (cg-RX-API-DMAC10.html) 1970-04-06 1971-03-30

Country Status (6)

Country Link
US (1) US3748325A (cg-RX-API-DMAC10.html)
CA (1) CA940927A (cg-RX-API-DMAC10.html)
CH (1) CH556847A (cg-RX-API-DMAC10.html)
DE (1) DE2114607A1 (cg-RX-API-DMAC10.html)
FR (1) FR2131843B1 (cg-RX-API-DMAC10.html)
GB (1) GB1298603A (cg-RX-API-DMAC10.html)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5006548A (en) * 1984-02-29 1991-04-09 Sawai Pharmaceutical Co., Ltd. Acrylamidobenzoic acid derivatives and their use
US5962457A (en) * 1996-05-15 1999-10-05 Pfizer Inc. 2,3 Disubstituted- (5,6)-heteroarylfused-pyrimidine-4-ones
US6323208B1 (en) 1997-09-05 2001-11-27 Pfizer Inc Atropisomers of 2,3-disubstituted-(5.6)-heteroaryl fused-pyrimidin-4-ones

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4832879A (en) * 1980-03-04 1989-05-23 Basf Aktiengesellchaft Substituted 3-fluoroalkoxybenzoyl halides and their preparation
WO1992013535A1 (en) * 1991-02-06 1992-08-20 Research Corporation Technologies, Inc. Anticonvulsant substituted quinazolones
US5283247A (en) * 1991-02-06 1994-02-01 Research Corporation Technologies, Inc. Anticonvulsant substituted quinazolones
TR199802296T2 (xx) 1996-05-15 1999-02-22 Pfizer Inc. Yeni 2,3 dis�bstit�te-4 (3H)-kinazolinonlar
AU732448B2 (en) * 1997-02-28 2001-04-26 Pfizer Products Inc. Atropisomers of 3-heteroaryl-4(3H)-quinazolinones for the treatment of neurodegenerative and CNS-trauma related conditions
ATE267817T1 (de) * 1997-02-28 2004-06-15 Pfizer Prod Inc Atropisomere von 3-aryl-4(3h)-chinazolinonen und ihre verwendung als ampa-rezeptor
ITMI20050261A1 (it) * 2005-02-21 2006-08-22 Carlo Ghisalberti Analoghi strutturali di avenatramidi loro uso in composizioni utili nel trattamento di disordini dermatologici
US9216177B2 (en) 2011-02-28 2015-12-22 Drexel University Small molecular inhibitors of RAD51 recombinase and methods thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE646988A (cg-RX-API-DMAC10.html) * 1963-04-25 1964-10-23

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE646988A (cg-RX-API-DMAC10.html) * 1963-04-25 1964-10-23

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5006548A (en) * 1984-02-29 1991-04-09 Sawai Pharmaceutical Co., Ltd. Acrylamidobenzoic acid derivatives and their use
US5962457A (en) * 1996-05-15 1999-10-05 Pfizer Inc. 2,3 Disubstituted- (5,6)-heteroarylfused-pyrimidine-4-ones
US6323208B1 (en) 1997-09-05 2001-11-27 Pfizer Inc Atropisomers of 2,3-disubstituted-(5.6)-heteroaryl fused-pyrimidin-4-ones

Also Published As

Publication number Publication date
GB1298603A (en) 1972-12-06
DE2114607A1 (de) 1972-10-05
US3748325A (en) 1973-07-24
FR2131843B1 (cg-RX-API-DMAC10.html) 1974-05-24
CH556847A (de) 1974-12-13
CA940927A (en) 1974-01-29

Similar Documents

Publication Publication Date Title
ATA96471A (cg-RX-API-DMAC10.html)
AU2044470A (cg-RX-API-DMAC10.html)
AU1146470A (cg-RX-API-DMAC10.html)
AU1473870A (cg-RX-API-DMAC10.html)
AU2017870A (cg-RX-API-DMAC10.html)
AU2085370A (cg-RX-API-DMAC10.html)
AU1326870A (cg-RX-API-DMAC10.html)
AU1833270A (cg-RX-API-DMAC10.html)
AU1716970A (cg-RX-API-DMAC10.html)
AU1517670A (cg-RX-API-DMAC10.html)
AU2130570A (cg-RX-API-DMAC10.html)
AU1336970A (cg-RX-API-DMAC10.html)
AR195465A1 (cg-RX-API-DMAC10.html)
AU1591370A (cg-RX-API-DMAC10.html)
AU1872870A (cg-RX-API-DMAC10.html)
AU2144270A (cg-RX-API-DMAC10.html)
AU2131570A (cg-RX-API-DMAC10.html)
AU1328670A (cg-RX-API-DMAC10.html)
AU2130770A (cg-RX-API-DMAC10.html)
AU1343870A (cg-RX-API-DMAC10.html)
AU1277070A (cg-RX-API-DMAC10.html)
AU2119370A (cg-RX-API-DMAC10.html)
AU1247570A (cg-RX-API-DMAC10.html)
AU1581370A (cg-RX-API-DMAC10.html)
AU1235770A (cg-RX-API-DMAC10.html)

Legal Events

Date Code Title Description
ST Notification of lapse